Scientists have reversed diabetic heart failure with a genetic therapy in mice and miniature human "hearts" grown from stem ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...

PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the ...

The gene therapy company uniQure has announced top-level data from its trial of AMT-130, a new gene therapy designed to treat Huntington’s disease.

Cellectis’ headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find ...

Researchers have achieved the first demonstration in mice of using gene therapy to reverse hallmark symptoms of SYNGAP1-related disorder, a devastating condition affecting an estimated 1 million ...

RJVA-002 achieved ~30% weight loss at five weeks in a translational obesity model; weight loss not yet plateauedPreclinical ...

Rocket has pulled an approval application to the FDA, with the biotech considering offloading the asset via external ...

"We're not a one-size-fits-all CDMO," said Min Park, CCO of Matica Bio. "Our team works closely with each partner to deliver ...